This inventor holds 1 USPTO granted patent and 1 published patent application and 7 EPO patents. Top assignee: Novartis Ag. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Achim Schlapbach: Innovator in Pharmaceutical Research
Introduction: Achim Schlapbach is a notable inventor based in Basel, Switzerland. He is currently associated with Novartis AG, a leading global healthcare company. Although he has not yet been granted any patents, his contributions to the field of pharmaceutical research are significant.
Latest Patent Applications: Achim Schlapbach has been involved in several innovative projects, leading to the following latest patent applications:
1. **Interleukin-17 Inhibitors** - This invention relates to novel pyridine-N oxide substituted 2-formamido (N-phenyl and N-pyridyl) acetamide compounds that are Interleukin-17 (IL-17) inhibitors. It includes processes for their preparation, pharmaceutical compositions, and medicaments containing them, as well as their use in diseases and disorders mediated by IL-17.
2. **Novel Pyrazolo Pyrimidine Derivatives** - This invention describes new pyrazolo-pyrimidine derivatives that interact with MALT1 proteolytic and/or autoproteolytic activity, particularly inhibiting said activity. It further details the synthesis of these new derivatives and their use as a medicament.
Conclusion: Achim Schlapbach is an innovative force in the pharmaceutical industry, contributing to the development of new therapeutic compounds. His ongoing research and patent applications reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile